Using primary care data to assess comparative effectiveness and safety of apixaban and rivaroxaban in patients with nonvalvular atrial fibrillation in the UK: an observational cohort study

Ashley Jaksa*, Liza Gibbs, Seamus Kent, Shaun Rowark, Stephen Duffield, Manuj Sharma, Lynne Kincaid, Ayad Ali, Amanda Patrick, Priya Govil, Pall Jonsson, Nicolle Gatto

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Scopus)
5 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Using primary care data to assess comparative effectiveness and safety of apixaban and rivaroxaban in patients with nonvalvular atrial fibrillation in the UK: an observational cohort study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science